Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who are candidates for advanced heart failure treatment and obtain insights into patient and physician decisions regarding referral for advanced heart failure therapy.
Study Type
OBSERVATIONAL
Enrollment
99
Rigshospitalet
Copenhagen, Denmark
CHU of Nantes
Nantes, France
Hannover Medical Center
Hanover, Germany
University Clinical Center Tuebingen
Tübingen, Germany
Proportion of patients
Proportion of heart failure patients followed in outpatient clinic that are NYHA III-IV with LVEF \</= 40% and a CRT and/or ICD who have an indication without contraindication for heart transplantationi and/or DT LVAD.
Time frame: 12 months
Reasons for non-referral
Assess physician's reasons for non-referral of patients for LVAD/transplant evaluation.
Time frame: 12 months
Patient's reasons
Assess patients reasons for declining LVAD/transplant as a treatment option.
Time frame: 12 months
Actual and predicted 12 month survival
Assess the actual and predicted 12 month survival (predicted by VO2, the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM)).
Time frame: 12 months
Simple clinical parameters for referral
Identify simple clinical parameters that can be used by physicians to refer patients for LVAD/transplant evaluation at an optimal time.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Erasmus Medical Center
Rotterdam, Netherlands
Karolinska University Hospital
Stockholm, Sweden
University Hospital of South Manchester NHS Trust
Manchester, United Kingdom